Journal of Alzheimer’s Disease Special Supplement Presents New Research Findings and Findings for Neuroscience
Every year, nearly ten million new cases of dementia occur worldwide, of which Alzheimer’s disease (AD) is the most common form, accounting for about 60 to 70%. Neuroscience attempts to unlock the brain’s secrets through translational research and drug discovery in order to improve the lives of individuals with a wide variety of neurological and psychiatric disorders such as AD, Parkinson’s disease, schizophrenia, depression, traumatic brain injury , epilepsy and many others.
A special supplement, published in the Journal of Alzheimer’s Disease, focused on the challenges posed by brain disease and showcased productive and collaborative research programs in Latin America that are facing critical challenges in brain research, which are currently making high-impact collaborative contributions to the field of neuroscience.
Topics highlighted include biomarkers in aging and age-related diseases, especially studies that seek cost-effective and time-effective approaches to measuring these markers; new molecules as neuroprotectors; cognition cognition studies in Hispanic populations to identify aspects of brain disease.
The article about the publication can be accessed here.